JAK1 and cancer: The potential role of apigenin as an anti-cancer agent was confirmed in HER2-overexpressing MCF-7 cells in which apigenin reduced tyrosine phosphorylation of HER2 and reduced expression of phosphorylated Janus kinase 1 (phospho-JAK1) and phospho-STAT3 [173].